No glucocorticoid use | ||||
Unadjusted* | Adjusted** | |||
HR (CI 95%) | P | HR (CI 95%) | P | |
Calprotectin | 1.002 (1.000 – 1.004) | 0.031 | 1.002 (1.000 – 1.004) | 0.016 |
Neutrophil count | 1.039 (0.978 – 1.103) | 0.213 | 1.035 (0.971 – 1.103) | 0.296 |
Lymphocyte count | 0.604 (0.475 – 0.768) | <0.01 | 0.667 (0.522 – 0.851) | <0.01 |
NLR | 1.104 (1.051 – 1.159) | <0.01 | 1.090 (1.036 – 1.148) | <0.01 |
YKL-40 | 1.001 (0.999 – 1.002) | 0.318 | 1.001 (1.000 – 1.003) | 0.086 |
Glucocorticoid use | Unadjusted* | |||
HR (CI 95%) | P | |||
Calprotectin | 1.001 (0.998 – 1.003) | 0.559 | ||
Neutrophil count | 1.035 (0.945 – 1.133) | 0.462 | ||
Lymphocyte count | 0.946 (0.580 – 1.545) | 0.825 | ||
NLR | 1.010 (0.966 – 1.056) | 0.665 | ||
YKL-40 | 1.006 (1.003 – 1.008) | <0.01 |